ICON Public Limited Company

ICLR ·Healthcare, Diagnostics & Research, Ireland
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $8.25B $8.19B $8.05B $7.74B $5.48B $2.80B $2.81B $2.60B
Cost of Revenue $6.08B $5.85B $5.72B $5.53B $3.97B $1.98B $1.97B $1.82B
Gross Profit $2.18B $2.34B $2.33B $2.21B $1.51B $817.4M $831.7M $777.6M
Gross Margin 26.4% 28.6% 29.0% 28.6% 27.5% 29.2% 29.6% 30.0%
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $780.1M $728.3M $768.6M $778.8M $585.3M $342.4M $332.7M $325.8M
Operating Income $442.8M $1.03B $904.7M $795.2M $378.5M $391.5M $433.4M $373.4M
Operating Margin 5.4% 12.6% 11.2% 10.3% 6.9% 14.0% 15.4% 14.4%
Interest Expense $188.1M $206.2M $336.7M $229.7M $182.4M $13.0M $13.3M $13.5M
Pretax Income $252.5M $803.8M $573.0M $567.9M $196.7M $381.2M $427.0M $364.6M
Income Tax Expense $23.1M $64.6M $18.4M $59.4M $41.3M $47.9M $51.1M $42.0M
Net Income $229.3M $739.1M $554.2M $505.3M $153.2M $332.3M $374.0M $322.7M
Net Margin 2.8% 9.0% 6.9% 6.5% 2.8% 11.9% 13.3% 12.4%
EPS (Basic) $2.92 $8.96 $6.75 $6.20 $2.28 $6.20 $6.85 $5.96
EPS (Diluted) $2.90 $8.90 $6.70 $6.13 $2.25 $6.15 $6.79 $5.89
Shares Outstanding (Basic) 78.4M 82.5M 82.1M 81.5M 67.1M 52.9M 53.9M 54.1M
Shares Outstanding (Diluted) 79.0M 83.0M 82.7M 82.5M 68.1M 53.3M 54.3M 54.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 3 Older →